Ignite Creation Date:
2025-12-24 @ 1:35 PM
Ignite Modification Date:
2026-02-22 @ 4:50 PM
Study NCT ID:
NCT03645395
Status:
TERMINATED
Last Update Posted:
2022-08-16
First Post:
2018-07-19
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Dose Regimens of MT-3724 With Lenalidomide for the Treatment of Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (MT-3724_NHL_003)
Sponsor:
Molecular Templates, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-04-08
Start Date Type:
ACTUAL
Primary Completion Date:
2021-03-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-03-10
Completion Date Type:
ACTUAL
First Submit Date:
2018-07-19
First Submit QC Date:
None
Study First Post Date:
2018-08-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-06-01
Results First Submit QC Date:
None
Results First Post Date:
2022-08-16
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-07-18
Last Update Post Date:
2022-08-16
Last Update Post Date Type:
ACTUAL